QuidelOrtho Corporation (QDEL)
QuidelOrtho Stock Gains Following Q4 Earnings Beat, Margins Contract
Despite solid performances by the Labs and Immunohematology units and China and Other regions, QDEL reports soft overall top-line results in fourth-quarter 2024.
QuidelOrtho Corporation (QDEL) Q4 2024 Earnings Call Transcript
QuidelOrtho Corporation (NASDAQ:QDEL ) Q4 2024 Results Conference Call February 12, 2025 5:00 PM ET Company Participants Juliet Cunningham - Vice President, Investor Relations Brian Blaser - President and Chief Executive Officer Joe Busky - Chief Financial Officer Conference Call Participants Jack Meehan - Nephron Research Patrick Donnelly - Citi Bill Bonello - Craig-Hallum Lu Li - UBS Andrew Cooper - Raymond James Casey Woodring - JPMorgan Andrew Brackmann - William Blair Jose Ricardo - RBC Capital Markets Operator Welcome to the QuidelOrtho Fourth Quarter and Full Year 2024 Financial Results Conference Call and Webcast. At this time, all participant lines are in a listen-only mode.
QuidelOrtho (QDEL) Q4 Earnings and Revenues Top Estimates
QuidelOrtho (QDEL) came out with quarterly earnings of $0.63 per share, beating the Zacks Consensus Estimate of $0.55 per share. This compares to earnings of $1.17 per share a year ago.
Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now
QDEL continues to witness growth on the back of its strong product portfolio.
QuidelOrtho Stock Down Despite Solid Preliminary Q4 Revenues
QDEL's preliminary fourth-quarter revenues align with the company's expectations.
Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now
QDEL continues to witness growth on the back of its strong product portfolio.
QuidelOrtho Stock Rises as Q3 Earnings & Revenues Beat Estimates
QDEL's third-quarter results reflect growth in non-respiratory revenues along with a lowering of operating expenses year over year. However, the gross margin declines in the reported quarter.
QuidelOrtho Corporation (QDEL) Q3 2024 Earnings Call Transcript
QuidelOrtho Corporation (NASDAQ:QDEL ) Q3 2024 Earnings Conference Call November 7, 2024 5:00 PM ET Company Participants Juliet Cunningham – Vice President, Investor Relations Brian Blaser – President and Chief Executive Officer Joe Busky – Chief Financial Officer Conference Call Participants Andrew Brackmann – William Blair Jack Meehan – Nephron Research Bill Bonello – Craig-Hallum Patrick Donnelly – Citi Andrew Cooper – Raymond James Jose Ricardo Moreno – RBC Capital Markets Casey Woodring – JPMorgan Operator Welcome to the QuidelOrtho Third Quarter 2024 Financial Results Conference Call and Webcast. At this time, all participant lines are in a listen-only mode.
QuidelOrtho (QDEL) Beats Q3 Earnings and Revenue Estimates
QuidelOrtho (QDEL) came out with quarterly earnings of $0.85 per share, beating the Zacks Consensus Estimate of $0.31 per share. This compares to earnings of $0.90 per share a year ago.
Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now
QDEL's strong product portfolio raises optimism about the stock.
Why QuidelOrtho Stock Blasted 10% Higher Today
An analyst became notably more bullish on the diagnostics company's prospects. He upgraded his recommendation from hold to buy.
Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now
QDEL's strong product portfolio raises optimism about the stock.
